Sponsors / Partners

Accenture Microsoft NYSE Shell Salesforce AAAS Science Red Herring Fortune CNN Time Magazine
 

2004 World Technology Awards Winners & Finalists

Epigenomics AG

Please describe the work that you are doing that you consider to be the most innovative and of the greatest likely long-term significance.

We are developing novel molecular diagnostic and pharmacodiagnostic products based on DNA methylation with an initial focus on cancer. Our products are based on our proprietary technology for the fast and flexible development of panels of methylation-based biomarkers for specified diagnostic and pharmacodiagnostic problems. Based on our findings to date, we believe that our approach will allow us to systematically and rapidly develop convenient high-quality products that will significantly improve the treatment of diseases, and in particular cancer.